Mitchell P. Kopin 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-17 4:44 pm Purchase | 2025-01-13 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 530,171 9.990% | 439,184 (+482.69%) | Filing |
| 2024-12-27 5:05 pm Purchase | 2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 90,987 4.990% | 45,782 (+101.28%) | Filing |
| 2024-11-13 11:20 am Purchase | 2024-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 45,205 4.990% | 45,205 (New Position) | Filing |